Company intelligence / Profile preview

AST

Tacoma, Washington, United States

Ownership: Private
Employees: ~51
Development stage: Other

Overview

AST is a leader in advanced aseptic fill-finish manufacturing equipment for biotechnology and pharmaceutical products, providing innovative, automated, and integrated cGMP solutions that support both clinical and commercial production of sterile injectable drugs, including for advanced therapeutics like biologics, cell, and gene therapies. The company does not itself run clinical programs, but its equipment is widely used by biopharma clients across the clinical pipeline.

Industry: Non-Drug Biotech

Partnerships

Major CDMOsPharmaceutical manufacturersBiotech firmsCompounding pharmaciesAcademic manufacturing centers

Beyond the preview

Go deeper on AST.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AST.

Explore the full profile